Teva Pharmaceutical Industries Limited (LON:0LER)

LON:0LER Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	29,850	26,604	19,974	9,188	8,407	6,525
Market Cap Growth	48.47%	33.19%	117.40%	9.29%	28.84%	-15.77%
Enterprise Value	39,770	37,669	32,974	23,815	25,127	23,592
Last Close Price	25.62	23.24	17.55	8.19	7.50	5.86
PE Ratio	28.49	25.40	-	-	-	21.19
PS Ratio	2.33	2.08	1.51	0.74	0.68	0.56
PB Ratio	5.08	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	35.00	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	24.36	21.71	20.05	8.56	6.37	11.07
EV/Sales Ratio	3.15	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	13.43	13.05	9.32	7.00	7.63	7.25
EV/EBIT Ratio	18.73	17.58	12.24	9.54	11.37	10.38
EV/FCF Ratio	46.63	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.16	2.16	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	4.24	4.24	3.98	4.53	5.26	5.19
Debt / FCF Ratio	14.89	14.89	24.28	24.08	20.80	99.97
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	4.50%	4.50%	5.09%	4.54%	3.63%	3.91%
Return on Invested Capital (ROIC)	13.23%	13.71%	14.73%	12.08%	8.85%	6.18%
Return on Capital Employed (ROCE)	10.60%	10.60%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	3.51%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	2.86%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.